Epigenetic reprogramming and hypothalamic changes in metabolic syndrome

FHS
July 30, 2024
6:11 pm

Metabolic syndrome (MetS) is a multifaceted disorder that impacts approximately 20–25% of the global population.

Protein Drivers of Heart Attack Risk Disproportionately Affect Women

Sex-specific molecules contributing to one’s risk of myocardial infarction (MI) were identified by researchers using proteomic profiling. Based on targeted cardio-metabolic proteomics on two large-scale

October 15, 2024

Half of IRA negotiation savings to come from three drugs, Brookings finds

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

August 20, 2024

Robotic arm-based, 5G-enabled remote echocardiograms show high diagnostic accuracy

New research presented at this year’s ESC Congress 2024 in London, UK (30 Aug – 2 Sept) shows that performing echocardiograms remotely using a 5G

August 28, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.